|
|
Aprepitant blocks the actions of chemicals in the body that may cause nausea and vomiting. Aprepitant is used to prevent nausea and vomiting associated with cancer chemotherapy. Aprepitant may also be used for purposes other than those listed in ...
|
||
|
Learn more about EMEND® (aprepitant) by visiting emend.com. ... EMEND has been used to help prevent nausea and vomiting in more than 3 million cycles of chemotherapy over 5 years. Learn more about EMEND.
|
||
|
Find Prescribing Information for EMEND® (aprepitant) at emend.com. ... Download Prescribing Information for EMEND in PDF format; [PDF: 222KB, 20 pages] ... Important information about EMEND...
|
||
|
Aprepitant - Wikipedia, the free encyclopedia
|
||
|
Emend (aprepitant) is used to prevent nausea and vomiting caused by surgery or chemotherapy. Includes Emend side effects, interactions and indications. ... Emend blocks the actions of chemicals in the body that trigger nausea and vomiting.
|
||
|
Learn about the prescription medication Emend Capsules (Aprepitant Capsules), drug uses, dosage, side effects, drug interactions, warnings, and patient labeling. ... Each capsule of EMEND for oral administration contains either 40 mg, 80 mg, or 125 mg of aprepitant and the following inactive ingredients:
|
||
INDICATIONS AND USAGE EMEND, in combination with other antiemetic agents, is indicated for the: prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin prevention of nausea and vomiting associated with initial...
|
||
EMEND®; (fosaprepitant dimeglumine) for Injection 9840004; 2; CLINICAL PHARMACOLOGY; Fosaprepitant, a prodrug of aprepitant, when administered intravenously is rapidly converted to aprepitant, a substance P/neurokinin 1 (NK1) receptor antagonist.
|